v3.26.3
SHAREHOLDERS’ EQUITY (Tables)
 6 Months Ended
Jun. 30, 2026
Equity, Attributable to Parent [Abstract]  
Schedule of Share Capital
   Number of shares as of
June 30, 2026		   Number of shares as of
December 31, 2025		 
   Authorized   Issued and outstanding   Authorized   Issued and outstanding 
Ordinary shares   100,000,000    55,406,688    100,000,000    35,949,247 
Schedule of Movement in Warrants Outstanding The following table reconciles the movement in warrants outstanding at the beginning and end of the period:
   Number of
Warrants		   Weighted-average
exercise price		   Weighted average remaining
contractual term
(in years)		 
Balance as of December 31, 2025   5,936,690    2.49    0.8 
Issued   12,343,097    0.38    5.1 
Reclassification of private warrants from financial liability at fair value into equity   3,031,250    0.7    4.61 
Exercised   (12,172,616)   0.5    1.17 
Expired   (301,429)   1.1    - 
Balance as of June 30, 2026   8,836,992    1.72    3.97 
Schedule of Information about the Company’s Outstanding Warrants The following table summarizes information about the Company’s outstanding warrants as of June 30, 2026.
Exercise Price  Warrants outstanding
as of
June 30,
2026		   Expiration date
5.5   1,640,455   15/07/2026
6.875   145,455   15/01/2027
1.6   205,027   28/06/2027
1.56   60,340   14/06/2028
0.7   6,785,715   05/08/2031
Balance as of June 30, 2026   8,836,992    
Schedule of Loss Per Share Calculated Using the Weighted Average Number of Ordinary Shares and Pre-Funded Warrants

Loss per share has been calculated using the weighted average number of shares in issue during the relevant financial periods, the weighted average number of equity shares in issue and profit for the period as follows:

 

   Year ended
June 30,
2026		   Year ended
June 30,
2025		 
Loss for the period   6,354    6,398 
Total number of Ordinary Shares   55,406,688    28,651,297 
Weighted average number of Ordinary Shares   44,566,144    26,782,603 
Basic and diluted loss per share   (0.14)   (0.24)